Similar Search Results

The New Prescription Drug Paradox : Pipeline Pressure and Rising Prices

Ellyson, Alice - 2018

competition after entry. However, less attention has been paid to pricing behavior in anticipation of brand-to-brand competition … manufacturers under tiered-insurance anticipating branded competition. Our model predicts rising prices for incumbent drugs for a …

Persistent link: https://www.econbiz.de/10012925274

The New Prescription Drug Paradox : Pipeline Pressure and Rising Prices

Ellyson, Alice M. - 2018

Persistent link: https://www.econbiz.de/10012453327

Competition between generic and brand name drugs : new evidence from the U.S. pharmaceutical market

Cavaliere, Alberto; Moayedizadeh, Ashin - 2022

Persistent link: https://www.econbiz.de/10014232582

Profit-seeking behavior of medical providers and generic competition in the pharmaceutical market : evidence from Taiwan

Liu, Ya Ming; Hsieh, Chee-Ruey - In: The B.E. journal of economic analysis & policy 14 (2014) 1, pp. 241-275

Persistent link: https://www.econbiz.de/10010345585

Pharmaceutical industry's changing market dynamics

Saha, Atanu; Roberts, Heather - In: International journal of the economics of business 27 (2020) 2, pp. 159-175

Persistent link: https://www.econbiz.de/10012253820

The competitive dynamics of the generic drug manufacturing industry

Hoffman, Evan - In: Business economics : the journal of the National … 52 (2017) 1, pp. 68-75

Persistent link: https://www.econbiz.de/10012013562

The interaction between leading drugs and pharmacy-owned labels in Chile

Escobar E., Gonzalo; Valdés de la Fuente, Iván - In: International journal of business environment : IJBE 14 (2023) 1, pp. 67-93

Persistent link: https://www.econbiz.de/10014234422

Collusion in the US generic drug industry

Clark, Robert; Fabiilli, Christopher Anthony; Lasio, Laura - 2021

We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a difference-in-differences approach comparing the evolution of prices of allegedly collusive drugs with a group of competitive control drugs. Our analysis highlights (i) the...

Persistent link: https://www.econbiz.de/10012670921

Pharmaceutical pricing in emerging markets : effects of income, competition, and procurement

Danzon, Patricia Munch; Mulcahy, Andrew W.; Towse, Adrian K. - In: Health economics 24 (2015) 2, pp. 238-252

Persistent link: https://www.econbiz.de/10011317852

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-Day exclusivity period

Olson, Luke M.; Wendling, Brett W. - 2013

Persistent link: https://www.econbiz.de/10010473653

1
2
3
4
5
6
7
8
9
10
Next
Last